| CYP51 | Lanosterol 14α-demethylase |
| MAFLD | Metabolic Associated Fatty Liver Disease |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| HCC | Hepatocellular Carcinoma |
| WT | Wild-Type |
| KO | Knock-Out |
| M | Month |
| W | Week |
| H&E | Hematoxylin and Eosin |
| SR | Sirius Red |
| FFA | Fatty Free Acids |
| TG | Triglycerides |
| BA | Bile Acids |
| CHOL | Cholesterol |
| HDL | High-Density Lipoprotein |
| ALT | Alanine Transaminase |
| AST | Aspartate Transaminase |
| LC-MS | Liquid Chromatography-Mass Spectrometry |
| HMGCR | 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase |
| DHCR24 | 24-dehydrocholesterol reductase |
| GEO | Gene Expression Omnibus |
| DE | Differentially Expression |
| ECM | Extracellular Matrix |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| EMT | Epithelial to Mesenchymal Transition |
| TF | Transcription Factor |